Efficacy and Safety of Tisagenlecleucel in Adult Patients With Refractory or Relapsed Follicular Lymphoma

Novartis Investigative Site, Camperdown

Novartis Investigative Site, Melbourne

Novartis Investigative Site, Linz

Novartis Investigative Site, Ghent

University of Pennsylvania Clinical, Philadelphia

Novartis Investigative Site, Milan

Novartis Investigative Site, Madrid

H Lee Moffitt Cancer Center and Research Institute, Tampa

Novartis Investigative Site, Bologna

Novartis Investigative Site, Seville

Novartis Investigative Site, Cologne

Uni of Chi Medi Ctr Hema and Onco, Chicago

Univ of Kansas Hosp and Med Ctr, Kansas City

Novartis Investigative Site, Pierre-Bénite

Novartis Investigative Site, Paris

MD Anderson Cancer Center, Houston

Novartis Investigative Site, Munich

Novartis Investigative Site, Ulm

UCSF Medical Center, San Francisco

Oregon Health Sciences University, Portland

City of Hope National Medical Center, Duarte

Michigan Med University of Michigan, Ann Arbor

Novartis Investigative Site, Herston

Novartis Investigative Site, Fukuoka

Novartis Investigative Site, Sapporo

Novartis Investigative Site, Sendai

Novartis Investigative Site, Amsterdam

Amsterdam UMC, locatie AMC, Amsterdam

Novartis Investigative Site, Oslo

Novartis Investigative Site, Birmingham

Novartis Investigative Site, London